MammaPrint has been validated in multiple clinical trials and studies, demonstrating its reliability and accuracy. The MINDACT trial is one of the largest studies that confirmed the test’s efficacy. It showed that MammaPrint could effectively stratify patients based on their risk of recurrence, thus aiding in personalized treatment planning.
